Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for TLPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 14.41M
March 31, 2026 18.48M
December 31, 2025 17.04M
September 30, 2025 19.18M
June 30, 2025 6.627M
March 31, 2025 5.599M
December 31, 2024 8.001M
September 30, 2024 9.641M
June 30, 2024 12.73M
March 31, 2024 16.33M
December 31, 2023 14.10M
September 30, 2023 18.31M
June 30, 2023 10.42M
March 31, 2023 14.24M
December 31, 2022 21.81M
September 30, 2022 27.54M
June 30, 2022 33.14M
March 31, 2022 -38.27M
December 31, 2021 -35.89M
September 30, 2021 -43.02M
June 30, 2021 -35.99M
March 31, 2021 -27.31M
December 31, 2020 -55.75M
September 30, 2020 -57.85M
June 30, 2020 -60.13M
Date Value
March 31, 2020 -55.28M
December 31, 2019 -41.42M
September 30, 2019 -28.27M
June 30, 2019 -18.42M
March 31, 2019 -7.891M
December 31, 2018 4.253M
September 30, 2018 -37.79M
June 30, 2018 -48.97M
March 31, 2018 -46.88M
December 31, 2017 -36.51M
September 30, 2017 -30.31M
June 30, 2017 -31.62M
March 31, 2017 -19.66M
December 31, 2016 -5.337M
September 30, 2016 3.272M
June 30, 2016 13.50M
March 31, 2016 23.44M
December 31, 2015 33.11M
September 30, 2015 39.97M
June 30, 2015 33.39M
March 31, 2015 41.08M
December 31, 2014 46.66M
September 30, 2014 59.08M
June 30, 2014 55.55M
March 31, 2014 65.06M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Omeros Corp. -51.35M
Hyperion DeFi, Inc. 101.93M
ANI Pharmaceuticals, Inc. 597.21M
Corcept Therapeutics, Inc. 705.78M
Veru, Inc. 28.38M

Shareholders Equity (Quarterly) Related Metrics